Milner Therapeutics Institute supports new £20 million MRC Hub to accelerate next-generation drug discovery
The Milner Therapeutics Institute (MTI) is proud to be part of a new £20 million Medical Research Council (MRC) investment that will establish a UK Pre-clinical Translational Models Hub. Led by Professor Matthias Zilbauer and Professor Bertie Göttgens of the Cambridge...
Milner Bio-incubator company Healthspan Biotics rebrands as OneCarbon
We are delighted to announce that one of our Bio-incubator companies, Healthspan Biotics, has rebranded to OneCarbon. The new name reflects the company’s pioneering research into one-carbon metabolism and marks the next chapter in its mission to develop...
Milner Institute joins o2h Discovery Platinum Partner Programme to expand support for emerging biotech companies
We are delighted to announce that we have joined the o2h Discovery Platinum Partner Programme, enabling eligible companies within our bio-incubator and wider affiliate network to access specialist drug discovery support through the o2h Kickstarter Award. As part of...
Milner Institute convenes science, industry, investors and charity funders for Pitch Day and Symposium
Researchers, entrepreneurs, investors and global pharmaceutical leaders gathered in Cambridge this week as the Milner Therapeutics Institute hosted its annual Pitch Day and 11th annual Therapeutics Symposium. Held over two consecutive days, these flagship events...